Outpatient Treatment with 131I-Anti-B1 Antibody: Radiation Exposure to Family Members
Frank J. Rutar,
Samuel C. Augustine,
David Colcher,
Jeffry A. Siegel,
David A. Jacobson,
Margaret A. Tempero,
Valorie J. Dukat,
Maribeth A. Hohenstein,
Lisa S. Gobar and
Julie M. Vose
Departments of Chemical and Radiation Safety, Pharmacy Practice, Pathology and Microbiology, Internal Medicine, and Radiology, University of Nebraska Medical Center, Omaha, Nebraska; Department of Hematology/Oncology, University of California, San Francisco, and Corixa Corp., South San Francisco, California; and Nuclear Physics Enterprises, Cherry Hill, New Jersey

View larger version (49K):
[in a new window]
|
FIGURE 1. Form used to determine whether patient can be released from hospital after radioimmunotherapy with 131I-anti-B1 antibody. S/N = serial number.
|
|
Copyright © 2001 by the Society of Nuclear Medicine.